Andrew Dudum - 16 Oct 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Oct 2025, 16:42:04 UTC
Prior SEC filing
19 Sep 2025
Next SEC filing
12 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kimberly Mather, Attorney-in-Fact for Andrew Dudum

Key filing fact

Andrew Dudum filed Form 4 for Hims & Hers Health, Inc. (HIMS) on 20 Oct 2025.

Key facts

  • This page summarizes Andrew Dudum's Form 4 filing for Hims & Hers Health, Inc. (HIMS).
  • 13 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 20 Oct 2025, 16:42.

Change

  • Previous filing in this sequence was filed on 19 Sep 2025.
  • Current net transaction value: -$10,725,435.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001837796 Primary reporting owner

Dudum Andrew

Relationship
Chief Executive Officer, Director, 10%+ Owner
Address
2269 CHESTNUT STREET, #523, SAN FRANCISCO
Signature
/s/ Kimberly Mather, Attorney-in-Fact for Andrew Dudum
Signature date
20 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIMS transaction

Class A Common Stock

Sale

Transaction value
$174,924
Shares
-2,792
Change %
-2.9%
Price
$62.65
Shares after
92,523
Date
16 Oct 2025
Ownership
Direct
Footnotes
F1, F2
HIMS transaction

Class A Common Stock

Sale

Transaction value
$2,452,248
Shares
-39,111
Change %
-41%
Price
$62.70
Shares after
55,947
Date
16 Oct 2025
Ownership
Held by Trustee of Dudum Family Community Property Trust
Footnotes
F1, F3
HIMS transaction

Class A Common Stock

Sale

Transaction value
$534,513
Shares
-8,423
Change %
-15%
Price
$63.46
Shares after
47,524
Date
16 Oct 2025
Ownership
Held by Trustee of Dudum Family Community Property Trust
Footnotes
F1, F4
HIMS transaction

Class A Common Stock

Options Exercise

Transaction value
$41,312
Shares
+17,001
Change %
+18%
Price
$2.43
Shares after
109,524
Date
16 Oct 2025
Ownership
Direct
Footnotes
F1
HIMS transaction

Class A Common Stock

Sale

Transaction value
$1,065,793
Shares
-17,001
Change %
-16%
Price
$62.69
Shares after
92,523
Date
16 Oct 2025
Ownership
Direct
Footnotes
F1, F5
HIMS transaction

Class A Common Stock

Options Exercise

Transaction value
$263,252
Shares
+108,334
Change %
+117%
Price
$2.43
Shares after
200,857
Date
16 Oct 2025
Ownership
Direct
Footnotes
F1
HIMS transaction

Class A Common Stock

Sale

Transaction value
$2,478,803
Shares
-39,531
Change %
-20%
Price
$62.71
Shares after
161,326
Date
16 Oct 2025
Ownership
Direct
Footnotes
F1, F6
HIMS transaction

Class A Common Stock

Sale

Transaction value
$664,627
Shares
-10,469
Change %
-6.5%
Price
$63.49
Shares after
150,857
Date
16 Oct 2025
Ownership
Direct
Footnotes
F1, F7
HIMS transaction

Class A Common Stock

Sale

Transaction value
$2,466,112
Shares
-39,332
Change %
-26%
Price
$62.70
Shares after
111,525
Date
16 Oct 2025
Ownership
Direct
Footnotes
F1, F8
HIMS transaction

Class A Common Stock

Sale

Transaction value
$148,009
Shares
-2,335
Change %
-2.1%
Price
$63.39
Shares after
109,190
Date
16 Oct 2025
Ownership
Direct
Footnotes
F1, F9
HIMS transaction

Class A Common Stock

Sale

Transaction value
$1,044,969
Shares
-16,667
Change %
-15%
Price
$62.70
Shares after
92,523
Date
16 Oct 2025
Ownership
Direct
Footnotes
F1, F5
HIMS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,194,545
Date
16 Oct 2025
Ownership
Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
HIMS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,016,871
Date
16 Oct 2025
Ownership
Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
HIMS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,286,627
Date
16 Oct 2025
Ownership
Held by Trustee of AD 2021 GRAT dated 11-1-2021
HIMS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
186,723
Date
16 Oct 2025
Ownership
Held by Trustee of AD 2025 GRAT dated 5-27-2025
HIMS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
508,030
Date
16 Oct 2025
Ownership
Held by Trustee of AD 2022 GRAT
HIMS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
321,657
Date
16 Oct 2025
Ownership
Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
HIMS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,584,506
Date
16 Oct 2025
Ownership
Held by Trustee of AD 2023 GRAT dated 9-5-2023

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HIMS transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-17,001
Change %
-50%
Price
$0.000000
Shares after
17,005
Date
16 Oct 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
17,001
Exercise price
$2.43
Footnotes
F1, F10
HIMS transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-108,334
Change %
-20%
Price
$0.000000
Shares after
431,395
Date
16 Oct 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
108,334
Exercise price
$2.43
Footnotes
F1, F11
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 11 footnotes

Footnote F1

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.

Footnote F2

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.50 - $62.87. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F3

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.215 - $63.13. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F4

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $63.31 - $63.59. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F5

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.25 - $62.94. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F6

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.22 - $63.18. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F7

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $63.25 - $63.63. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F8

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.22 - $63.20. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F9

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $63.26 - $63.47. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F10

Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Footnote F11

The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .